Xeomin: Refined Results,Naturally You

Discover Xeomin, a purified neurotoxin that smoothes fine lines and wrinkles while preserving your natural expressions. Experience a refreshed appearance without compromising your unique beauty.

Face Image Placeholder

Illustration of a face with smooth lines

What is Xeomin?

Xeomin is a prescription medicine that contains incobotulinumtoxin A, a purified form of botulinum toxin type A derived from the bacteria that causes botulism. It works by blocking nerve activity in muscles, which temporarily reduces muscle activity and leads to muscle relaxation.

Uses of Xeomin

Xeomin is used for both cosmetic and medical purposes:

Cosmetic use: It is injected into muscles to improve the appearance of moderate to severe upper facial lines such as frown lines, forehead lines, and crow's feet in adults, providing temporary smoothing of wrinkles.

Medical use: Xeomin treats several conditions involving muscle overactivity or spasms, including:

  • Cervical dystonia (abnormal head position and neck pain due to muscle spasms) in adults.
  • Blepharospasm (involuntary eyelid spasms) in adults.
  • Increased muscle stiffness (spasticity) in the arms for adults and children aged 2 to 17 years (excluding spasticity caused by cerebral palsy).
  • Chronic drooling (sialorrhea) in adults and children aged 2 years and older.
Xeomin injection for wrinkles
Xeomin product

Benefits of Xeomin

Natural-Looking Results

Xeomin targets specific muscles responsible for wrinkles, allowing you to maintain your natural expressions.

Proven Safety

Xeomin has a well-established safety profile with extensive clinical testing and years of real-world use.

Long-Lasting Effects

Results typically last for 3-4 months, providing a sustained improvement in the appearance of wrinkles.

Xeomin is known for delivering subtle, natural-looking results. It targets specific muscles responsible for wrinkles, allowing your expressions to remain fresh. This ensures that your facial expressions remain authentic and expressive, avoiding the "frozen" appearance sometimes associated with other treatments. Xeomin has a well-established safety profile, with reference clinical testing for effectiveness and tolerability. It is administered by trained healthcare professionals, ensuring precise and safe treatment. The effects of Xeomin typically last for 3-4 months, providing a sustained improvement in the appearance of wrinkles. This allows you to enjoy the benefits of a refreshed look without frequent treatments.

Why Choose Xeomin

Choosing Xeomin means opting for a treatment that prioritizes both effectiveness and natural aesthetics. Its unique purification process minimizes unnecessary proteins, potentially reducing the risk of antibody formation and ensuring consistent results. Xeomin's formulation is designed to preserve your natural facial expressions, providing a refreshed appearance without compromising your unique beauty. With a proven safety record and long-lasting effects, Xeomin offers a reliable solution for those seeking to smooth fine lines and wrinkles while maintaining their authentic self.

Frequently Asked Questions

Xeomin results typically last between 3-4 months. Individual results may vary based on factors like muscle activity, age, and lifestyle.

Clinical Research Paper Reference

For further information on the clinical efficacy and safety of Xeomin, refer to the following research papers:

  1. Park JY et al. Plast Recontr Surg Glob Open. 2020:8(1)e2627
  2. Kerscher M, et al. J Drugs Dermatol. 2019 Jan 1:18(1):52-57
  3. Rzany B., et al. Dermatol Surg 2013; 95-103.
  4. Imhof M, Kühne U. A Phase ilI Study of IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines. 2011; 4(10):28-34
  5. Prager W, et al. Clin Interv Aging. 2013;8:449-56
  6. Rappi T, et al. Clin Cosmet Investig Dermatol. 2013; Sep 24: 6:211-19
  7. Kane MA, et al. Dermatol Surg. 2015;41(11):1319.
  8. Sattler G, et al. Dermatol Surg 2010;36(Suppl 4):2146–54
  9. Prager W, et al. Dermatol Surg 2010; 36(Suppl 4):2155–60.
  10. Fischer T, et al. J Drugs Dermatol. 2020;19(5):461-469.
  11. Chao YY, et al. J Clin Aesthet Dermatol. 2019;12(12):E53-E57
  12. Saybel A, et al. J Drugs Dermatol 2015;14(11):1291-1296.
  13. XEOMIN® Approved Product Information. Aug 2021.

Ready to Experience Xeomin?

Contact us to discuss if Xeomin is right for you and to develop a personalized treatment plan.

Contact Us